| Literature DB >> 29674973 |
Xiaoping Yin1, Xu Huang2, Qiao Li2, Li Li2, Pei Niu2, Minglu Cao2, Fei Guo3, Xuechao Li3, Wenchang Tan2,4,5, Yunlong Huo2,3,4.
Abstract
Background: The formation of hepatic hemangiomas (HH) is associated with VEGF and IL-7 that alter conduit arteries and small arterioles. To our knowledge, there are no studies to investigate the effects of HH on the hemodynamics in conduit arteries. The aim of the study is to perform morphometric and hemodynamic analysis in abdominal conduit arteries and bifurcations of HH patients and controls.Entities:
Keywords: abdominal arterial tree; computer tomography; hemodynamics; hepatic hemangioma; morphology
Year: 2018 PMID: 29674973 PMCID: PMC5895747 DOI: 10.3389/fphys.2018.00334
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Geometrical models reconstructed from CT images of a representative control (A) and a representative HH patient (B). (B) Also shows CT-axial angiographs, where arrows mark liver hemangiomas.
Figure 2(A) Schematic diagram of aorta and primary branches, where AA, ascending aorta; AOA, arch of aorta; DA, descending aorta; TA, thoracic aorta; RSA, right subclavian artery; RCCA, right common carotid artery; LCCA, left common carotid artery; LSA, left subclavian artery; CeTA, celiac trunk artery; CHA, common hepatic artery; SA, splenic artery; RRA, right renal artery; LRA, left renal artery; SMA, superior mesenteric artery; RIIA, right internal iliac artery; REIA, right external iliac artery; LIIA, left internal iliac artery; LEIA, left external iliac artery; and (B) zoomed diagram of CeTA and CHA, where the black dotted line represents the centerline, A0 refers to the intersection of centerlines between CeTA and CHA, and L and Ldenote the linear and arc lengths from point A0 to A, respectively.
Demographics and morphometry in each patient of control and HH groups.
| Control group | 1 | M | 31 | 3.14 | 5.47 | 18.11 | 17.17 | 17.79 | 0.57 | 0.17 | 0.3 | 0.96 |
| 2 | M | 37 | 3.02 | 7.16 | 20.23 | 58.39 | 84.53 | 0.42 | 0.15 | 0.35 | 0.69 | |
| 3 | M | 40 | 2.62 | 5.08 | 17.83 | 25.96 | 37.91 | 0.52 | 0.15 | 0.28 | 0.68 | |
| 4 | M | 46 | 2.96 | 5.77 | 20.64 | 41.47 | 53.21 | 0.51 | 0.14 | 0.28 | 0.78 | |
| 5 | M | 52 | 3.32 | 7.04 | 18.76 | 50.62 | 53.74 | 0.47 | 0.18 | 0.38 | 0.94 | |
| 6 | M | 52 | 1.99 | 5.93 | 18.14 | 46.43 | 60.47 | 0.34 | 0.11 | 0.33 | 0.77 | |
| 7 | F | 55 | 2.9 | 4.86 | 19.85 | 35.73 | 41.55 | 0.6 | 0.15 | 0.24 | 0.86 | |
| 8 | M | 58 | 3.34 | 4.59 | 20.02 | 33.43 | 33.84 | 0.73 | 0.17 | 0.23 | 0.99 | |
| 9 | F | 62 | 2.91 | 6.35 | 23.78 | 32.78 | 39.03 | 0.46 | 0.12 | 0.27 | 0.84 | |
| HH group | 1 | F | 28 | 7.85 | 6.58 | 17.76 | 46.85 | 55.29 | 1.19 | 0.44 | 0.37 | 0.85 |
| 2 | M | 42 | 4.41 | 7.07 | 21.49 | 46.52 | 75.68 | 0.62 | 0.21 | 0.33 | 0.61 | |
| 3 | M | 43 | 4.88 | 7.54 | 23.76 | 59.23 | 94.12 | 0.65 | 0.21 | 0.32 | 0.63 | |
| 4 | F | 50 | 3.85 | 6.94 | 17.54 | 33.43 | 40.67 | 0.55 | 0.22 | 0.4 | 0.82 | |
| 5 | M | 50 | 4.81 | 7.77 | 21.67 | 52.97 | 66.36 | 0.62 | 0.22 | 0.36 | 0.80 | |
| 6 | F | 50 | 4.21 | 5.94 | 23.3 | 71.82 | 97.12 | 0.71 | 0.18 | 0.25 | 0.74 | |
| 7 | F | 52 | 3.65 | 4.76 | 21.34 | 32.08 | 51.73 | 0.77 | 0.17 | 0.22 | 0.62 | |
| 8 | F | 62 | 5.51 | 5.94 | 19.34 | 36.22 | 44.57 | 0.93 | 0.28 | 0.31 | 0.81 | |
| 9 | M | 63 | 4.92 | 7.24 | 19.97 | 25.07 | 45.48 | 0.68 | 0.25 | 0.36 | 0.55 | |
| 10 | F | 65 | 2.46 | 4.52 | 21.75 | 29.06 | 48.06 | 0.54 | 0.11 | 0.21 | 0.60 | |
| 11 | M | 67 | 5.84 | 7.61 | 25.75 | 37.81 | 54.46 | 0.77 | 0.23 | 0.3 | 0.69 | |
| 12 | F | 69 | 3.76 | 7.08 | 23.69 | 40.95 | 69.94 | 0.53 | 0.16 | 0.3 | 0.59 |
Statistical analysis of morphometric and hemodynamic parameters in control and HH groups.
| Mean ± SD | 2.9 ± 0.4 | 4.7 ± 1.4 | <0.05 | |
| 95% CI | 2.6–3.2 | 3.8–5.5 | ||
| Mean ± SD | 5.8 ± 0.9 | 6.6 ± 1.1 | 0.099 | |
| 95% CI | 5.1–6.5 | 5.9–7.3 | ||
| Mean ± SD | 19.7 ± 1.9 | 21.5 ± 2.5 | 0.094 | |
| 95% CI | 18.3–21.1 | 19.9–23.0 | ||
| Mean ± SD | 38 ± 12.7 | 42.7 ± 13.6 | 0.432 | |
| 95% CI | 28.2–47.8 | 34.1–51.3 | ||
| Mean ± SD | 46.9 ± 19 | 62.0 ± 19.0 | 0.088 | |
| 95% CI | 32.3–61.5 | 49.9–74.0 | ||
| Mean ± SD | 0.51 ± 0.11 | 0.71 ± 0.19 | <0.05 | |
| 95% CI | 0.43–0.6 | 0.59–0.83 | ||
| Mean ± SD | 0.15 ± 0.02 | 0.22 ± 0.08 | <0.05 | |
| 95% CI | 0.13–0.17 | 0.17–0.27 | ||
| Mean ± SD | 0.3 ± 0.05 | 0.31 ± 0.06 | 0.566 | |
| 95% CI | 0.26–0.33 | 0.27–0.35 | ||
| Mean ± SD | 0.84 ± 0.11 | 0.69 ± 0.11 | <0.05 | |
| 95% CI | 0.75–0.92 | 0.63–0.76 | ||
| DInlet (mm) | 21.5 ± 2.1 | 22.3 ± 3.4 | 0.704 | |
| Remean | 1028 ± 101 | 1065 ± 163 | 0.704 | |
| SAR-TAWSS (%) | 4 ± 5 | 14.3 ± 4.4 | <0.05 | |
| SAR-TAWSSG (%) | 27 ± 38 | 36.1 ± 28.5 | 0.678 | |
| SAR-TAWSS (%) | <0.1 | 6.3 ± 5.1 | <0.05 | |
| SAR-TAWSSG (%) | 68 ± 33 | 55.4 ± 17.1 | 0.445 | |
| SAR-TAWSS (%) | 17 ± 22 | 43.6 ± 8.4 | <0.05 | |
| SAR-TAWSSG (%) | 1 ± 1 | 2.1 ± 1.3 | 0.17 | |
Figure 3(A) A geometrical model for flow simulations, (B) the inlet flow waveform measured at a patient TA by phase-contrast MRI, and (C) FE meshes at a cross-sectional area.
Figure 4(A) Flow streamlines (unit: s−1) at time instances with the highest and lowest flow velocities at the inlet of TA (i.e., t1 and t2 in Figure 3B), (B) TAWSS (unit: dynes/cm2), and (C) TAWSSG (unit: dynes/cm3) in a representative control and a representative HH patient.
Figure 5Bifurcation flow streamlines (A) and vortex cores (B) (unit: s−1) in a representative control and a representative HH patient at time instances with the highest and lowest flow velocities at the inlet of TA.